Toronto Dominion Bank My Md Pharmaceuticals, Inc. Transaction History

Toronto Dominion Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 14, 2024	BUY	$1.44 - $2.26 $93 - $146	65 New	65 $0
Q2 2023 Aug 10, 2023	BUY	$1.44 - $2.26 $93 - $146	65 New	65 $0
Q2 2022 Aug 11, 2022	BUY	$2.0 - $4.78 $128 - $305	64 Added 120.75%	117 $0
Q1 2022 May 09, 2022	SELL	$3.34 - $6.05 $1,576 - $2,855	-472 Reduced 89.9%	53 $0
Q4 2021 Feb 04, 2022	BUY	$5.46 - $9.69 $2,375 - $4,215	435 Added 483.33%	525 $3,000
Q3 2021 Nov 08, 2021	BUY	$4.64 - $7.94 $417 - $714	90 New	90 $1,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.